In addition, benign prostatic hyperplasia showed a significantly lower pattern for the CD34- cell population reported to control cases (32.69 ± 11.30 vs. 45.25 ± 0.52, p < 0.01, Table 2), which characterized the tumoral cells’ adhesion to endothelial cells from larger veins and arteries. This evidence concerns the gene CD34 and benign prostatic hyperplasia.